Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL D WOOLMAN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1508833450
CMS profile
1174528
Location
OGDEN, UT

General Payments · PY2018–2024

$7,721.70

  • Reported across 50 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,772.69

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $1,285.77 7
Food and Beverage $486.92 8

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $1,772.69 15

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,530.88 7
PY2019 $400.00 1
PY2022 $2,533.68 12
PY2023 $1,484.45 15
PY2024 $1,772.69 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $107.06 09/06/2024 Food and Beverage Undisputed 01/23/2026 1104220615 CMS
AstraZeneca Pharmaceuticals LP $97.78 09/06/2024 Food and Beverage Undisputed 01/23/2026 1104518054 CMS
AstraZeneca Pharmaceuticals LP $71.24 09/06/2024 Food and Beverage Undisputed 01/23/2026 1104541770 CMS
AstraZeneca Pharmaceuticals LP $415.94 09/06/2024 Travel and Lodging Undisputed 01/23/2026 1104615246 CMS
AstraZeneca Pharmaceuticals LP $27.94 09/06/2024 Food and Beverage Undisputed 01/23/2026 1104761732 CMS
AstraZeneca Pharmaceuticals LP $292.33 09/06/2024 Travel and Lodging Undisputed 01/23/2026 1104778096 CMS
AstraZeneca Pharmaceuticals LP $80.92 09/06/2024 Travel and Lodging Undisputed 01/23/2026 1105216251 CMS
AstraZeneca Pharmaceuticals LP $27.94 09/06/2024 Food and Beverage Undisputed 01/23/2026 1105267672 CMS
AstraZeneca Pharmaceuticals LP $71.24 09/06/2024 Food and Beverage Undisputed 01/23/2026 1105309410 CMS
AstraZeneca Pharmaceuticals LP $24.44 09/06/2024 Food and Beverage Undisputed 01/23/2026 1105392944 CMS
AstraZeneca Pharmaceuticals LP $292.33 09/06/2024 Travel and Lodging Undisputed 01/23/2026 1105612957 CMS
AstraZeneca Pharmaceuticals LP $123.68 09/06/2024 Travel and Lodging Undisputed 01/23/2026 1105690895 CMS
AstraZeneca Pharmaceuticals LP $57.64 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1104620876 CMS
AstraZeneca Pharmaceuticals LP $59.28 11/13/2024 Food and Beverage Undisputed 01/23/2026 1104698582 CMS
AstraZeneca Pharmaceuticals LP $22.93 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1105293775 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.